Ritonavir-boosted darunavir is rarely associated with nephrolithiasis compared with ritonavir-boosted atazanavir in HIV-infected patients
about
Cholelithiasis and Nephrolithiasis in HIV-Positive Patients in the Era of Combination Antiretroviral TherapyProjected Uptake of New Antiretroviral (ARV) Medicines in Adults in Low- and Middle-Income Countries: A Forecast Analysis 2015-2025.Clinical features and risk factors for atazanavir (ATV)-associated urolithiasis: a case-control study.Relationships between Serum Levels of Atazanavir and Renal Toxicity or Lithiasis.Comparison of atazanavir/ritonavir and darunavir/ritonavir based antiretroviral therapy for antiretroviral naïve patients.Improved kidney function in patients who switch their protease inhibitor from atazanavir or lopinavir to darunavir.Monitoring of kidney function in HIV-positive patients.Acute Care Management of the HIV-Infected Patient: A Report from the HIV Practice and Research Network of the American College of Clinical Pharmacy.[Treatment of HIV-infected patients: metabolism, bone, cardiovascular - what is part of routine care?]Human immunodeficiency virus (HIV)-related stone disease - a potential new paradigm?Renal effects of non-tenofovir antiretroviral therapy in patients living with HIV.PharmGKB summary: atazanavir pathway, pharmacokinetics/pharmacodynamics
P2860
Q28547869-1073F41F-E684-479A-956E-CF68A8E92F37Q30394059-3BE62E08-67C2-4E78-B9A7-535FB6ACD944Q34542154-BA8A7C17-F693-4B62-BA68-E3A853D66236Q35630635-BC25D856-848B-4526-A616-CA8953985E6FQ36343716-0BD7022A-8308-409E-91FB-D64FD7E532DDQ37613237-F244C9A9-9600-45AA-9B0A-E4EE2D9F46F4Q38461294-91065EA8-DE6E-45B7-8FC4-B4A7E7F6CE47Q38920747-2221D083-2241-421D-A519-0FB8A02C9902Q40179340-95F40C2E-F113-4DD9-A026-6CAF7759C685Q41688518-DF6E42EA-C6F7-48C3-85A9-7BDE414FF90AQ54240869-2856DF3A-8395-4293-ABFF-D0A07016B1C0Q57403878-11609FC5-51C4-44B8-85BC-D94E5D47D118
P2860
Ritonavir-boosted darunavir is rarely associated with nephrolithiasis compared with ritonavir-boosted atazanavir in HIV-infected patients
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
Ritonavir-boosted darunavir is ...... navir in HIV-infected patients
@ast
Ritonavir-boosted darunavir is ...... navir in HIV-infected patients
@en
type
label
Ritonavir-boosted darunavir is ...... navir in HIV-infected patients
@ast
Ritonavir-boosted darunavir is ...... navir in HIV-infected patients
@en
prefLabel
Ritonavir-boosted darunavir is ...... navir in HIV-infected patients
@ast
Ritonavir-boosted darunavir is ...... navir in HIV-infected patients
@en
P2093
P2860
P1433
P1476
Ritonavir-boosted darunavir is ...... navir in HIV-infected patients
@en
P2093
Hirokazu Komatsu
Hiroyuki Gatanaga
Katsuji Teruya
Koji Watanabe
Kunihisa Tsukada
Shinichi Oka
Takeshi Nishijima
Yohei Hamada
Yoshimi Kikuchi
P2860
P304
P356
10.1371/JOURNAL.PONE.0077268
P407
P577
2013-10-10T00:00:00Z